Literature DB >> 11167882

Reduction of experimental adhesion formation by inhibition of plasminogen activator inhibitor type 1.

K Falk1, P Björquist, M Strömqvist, L Holmdahl.   

Abstract

BACKGROUND: Adhesion formation is a common cause of complications following surgery. A reduction in peritoneal fibrinolytic capacity during operation is a key mechanism in the early formation of adhesions. An increase in the main inhibitor of fibrinolysis, plasminogen activator inhibitor type 1 (PAI-1), is a major factor in the loss of fibrinolytic activity. The aim of this study was to investigate if inhibition of PAI-1 could reduce the formation of adhesions after surgery.
METHODS: Mice (n = 53) were subjected to a standard surgical procedure in order to induce adhesion formation to the abdominal side wall. At the conclusion of the operation, fragments for antigen binding of polyclonal rabbit antibody against PAI-1 (PRAP-1) were injected intraperitoneally, at two different concentrations. Control animals received an equal volume of the vehicle (saline). One week after operation adhesion formation was quantified.
RESULTS: Both doses of PRAP-1 significantly reduced adhesion formation compared with the saline control (P = 0.003 and P = 0.002). There were no signs of bleeding in the postoperative period or at reoperation.
CONCLUSION: The present observations lend further support to the hypothesis of a pivotal role of fibrinolysis in the early formation of adhesions, and open up new possibilities for adhesion reduction by inhibiting PAI-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11167882     DOI: 10.1046/j.1365-2168.2001.01647.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  23 in total

Review 1.  Prevention of peritoneal adhesions: a promising role for gene therapy.

Authors:  Hussein M Atta
Journal:  World J Gastroenterol       Date:  2011-12-14       Impact factor: 5.742

Review 2.  Cytokine orchestration in post-operative peritoneal adhesion formation.

Authors:  Ronan A Cahill; H Paul Redmond
Journal:  World J Gastroenterol       Date:  2008-08-21       Impact factor: 5.742

3.  Effect of acidosis on expression of mesothelial cell plasminogen activator inhibitor type-1.

Authors:  M Bergström; P Falk; L Holmdahl
Journal:  Surg Endosc       Date:  2006-05-26       Impact factor: 4.584

4.  Application of hyaluronic acid/sodium alginate-based microparticles to prevent tissue adhesion in a rabbit model.

Authors:  Ja Hoon Back; Wan Jin Cho; Jun Ho Kim; Il Kyu Park; Sung Won Kwon
Journal:  Surg Today       Date:  2015-05-20       Impact factor: 2.549

5.  Histopathological Response and Adhesion Formation After Omentectomy with Ultrasonic Energy, Bipolar Sealing, and Suture Ligation.

Authors:  Gultekin Ozan Kucuk; Metin Ertem; Nuray Kepil
Journal:  Indian J Surg       Date:  2013-11-11       Impact factor: 0.656

6.  Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity.

Authors:  Cary B Aarons; Philip A Cohen; Adam Gower; Karen L Reed; Susan E Leeman; Arthur F Stucchi; James M Becker
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

7.  Reduction of adhesion formation by an angiotensin type 1 receptor antagonist.

Authors:  Yasuyuki Tokinaga; Yoshiki Kimoto; Koji Ogawa; Kazuhiro Mizumoto; Kazuaki Tange; Yoshio Hatano
Journal:  Langenbecks Arch Surg       Date:  2010-07-01       Impact factor: 3.445

8.  Characterization of a small molecule inhibitor of plasminogen activator inhibitor type 1 that accelerates the transition into the latent conformation.

Authors:  Ola Fjellström; Johanna Deinum; Tove Sjögren; Carina Johansson; Stefan Geschwindner; Viveca Nerme; Anne Legnehed; Jane McPheat; Karolina Olsson; Cristian Bodin; Amalia Paunovic; David Gustafsson
Journal:  J Biol Chem       Date:  2012-11-15       Impact factor: 5.157

9.  TGF-β1 Suppresses Plasmin and MMP Activity in Flexor Tendon Cells via PAI-1: Implications for Scarless Flexor Tendon Repair.

Authors:  Youssef M Farhat; Alaa A Al-Maliki; Anas Easa; Regis J O'Keefe; Edward M Schwarz; Hani A Awad
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

10.  An FDA approved neurokinin-1 receptor antagonist is effective in reducing intraabdominal adhesions when administered intraperitoneally, but not orally.

Authors:  Rizal Lim; Jonathan M Morrill; Scott G Prushik; Karen L Reed; Adam C Gower; Susan E Leeman; Arthur F Stucchi; James M Becker
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.